Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptomic analysis and high throughput functional characterization of human induced pluripotent stem cell derived sensory neurons.

Neurobiology of pain (Cambridge, Mass.)·2026
Same author

Editorial: Targeting ion channels for drug discovery: emerging challenges for high throughput screening technologies.

Frontiers in molecular neuroscience·2024
Same author

There is no F in APC: Using physiological fluoride-free solutions for high throughput automated patch clamp experiments.

Frontiers in molecular neuroscience·2022
Same author

Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia.

Molecular pharmacology·2022
Same author

Publisher Correction: Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells.

Scientific reports·2020
Same author

A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model.

Journal of pharmacological and toxicological methods·2020

Related Experiment Video

Updated: Jun 1, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Transient receptor potential A1 modulators.

Tim Strassmaier1, Rajagopal Bakthavatchalam

  • 1Hydra Biosciences, 790 Memorial Drive, Cambridge, MA 02139, USA.

Current Topics in Medicinal Chemistry
|June 16, 2011
PubMed
Summary
This summary is machine-generated.

Transient Receptor Potential Ankyrin 1 (TRPA1) channels are activated by irritants and involved in pain and inflammation. This review explores TRPA1 modulators, highlighting their therapeutic potential for pain and inflammatory conditions.

More Related Videos

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Related Experiment Videos

Last Updated: Jun 1, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Transient Receptor Potential Ankyrin 1 (TRPA1) is a non-selective cation channel superfamily member.
  • TRPA1 plays a role in various physiological functions, including pain and inflammation.
  • Activation of TRPA1 by chemical irritants and inflammatory compounds is well-documented.

Purpose of the Study:

  • To review known classes of molecules that modulate TRPA1 activity.
  • To provide an overview of the structure and activity of TRPA1 agonists and antagonists.
  • To highlight the therapeutic potential of targeting TRPA1 for pain and inflammation.

Main Methods:

  • Literature review of scientific articles on TRPA1 modulators.
  • Analysis of structure-activity relationships for identified TRPA1 agonists and antagonists.
  • Synthesis of information on chemical irritants and endogenous compounds activating TRPA1.

Main Results:

  • Identified broad classes of TRPA1 agonists and antagonists.
  • Summarized the structural features and mechanisms of action for various TRPA1 modulators.
  • Highlighted the link between TRPA1 activity and pain/inflammation pathways.

Conclusions:

  • TRPA1 is a promising therapeutic target for managing pain and inflammatory diseases.
  • Understanding TRPA1 modulators is crucial for developing novel therapeutics.
  • Further research into TRPA1 structure and function may yield new drug candidates.